Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP1 | Q9NZ08 | 8/20 | 0.33 |
| ▸ | ANPEP | P15144 | 8/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 6/20 | 0.33 |
| ▸ | CTSC | P53634 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 6/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7397874 | 0.85 | CTSC (0.32) | CTSCSSTR4CTSLGHSR | |
| SCHEMBL7356049 | 0.84 | CTSC (0.34) | CTSCSSTR4GHSR | |
| SCHEMBL27380018 | 0.80 | SLC1A1 (0.41) | ERAP1ANPEPERAP2CTSCLAP3 | |
| SCHEMBL7411955 | 0.80 | SLC1A1 (0.41) | ERAP1ANPEPERAP2CTSCLAP3 | |
| SCHEMBL7360267 | 0.80 | CTSL (0.40) | CTSCCTSL | |
| SCHEMBL7379883 | 0.78 | MC4R (0.38) | ERAP1ANPEPERAP2CTSCSSTR4 | |
| SCHEMBL7350474 | 0.76 | CTSL (0.44) | CTSCCTSL | |
| SCHEMBL8691960 | 0.76 | CTSC (0.33) | CTSCSSTR4GHSR | |
| SCHEMBL7354041 | 0.76 | CTSL (0.43) | CTSCCTSL | |
| SCHEMBL7414186 | 0.76 | CTSC (0.33) | CTSCSSTR4GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5776718-A | Reversible protease inhibitors | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817778-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030353-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-10-03 | — | — | WO | disclosed |